What an awesome NR. The platform therapy model that Dr. Miller spoke to at the AGM is blazing forward on efficiency, higher yields, cost effectiveness. We have a great R&D partnership with the McMaster team. We have continuing patent protections. We have a very competent and well connected new board member with years of senior Pharma experience to support and advise on both strategy and tactic. ZEN...soon to BOOM

BTW, ZEN has 11 months of cash cover at their current budgeted burn rate. Also, wondering what kind of financing you are expecting soon. No chance in hell they would ever do a private placement at the current share prices or anything under 5.85 Cdn on principle. There are so many other forms of financing options out there that do not include equity and dilution. Think about the vast number of projects with partnership/funding options open to them.